© РИА Томск. Павел Стефанский
TOMSK, Nov
15 – RIA Tomsk. Scientists of laboratories of new dosage forms of the RASA
Center at the Tomsk Polytechnical University (TPU) suggest to struggle with
swine influenza (H1N1), without inventing new vaccines, and
"delivering" substances increasing immunity in organism cells,
vulnerable for the virus, the press service of the higher education institution
reported.
© РИА Томск. Павел Стефанский
Earlier it
was reported that the laboratory which scientists are engaged in development of
remotely-controlled systems for delivery of drugs in a specific point of an
organism of the patient, was opened in TPU at the beginning of 2016. The
laboratory was headed by professors Gleb Sukhorukov (Queen Mary University of
London) and Dmitry Gorin (Saratov State University).
According
to TPU, scientists of the laboratory in particular are engaged in development
of the new method of combating against swine influenza. They suggest to
activate immunity by means of hybrid microcontainers with anti-virus RNA
(ribonucleic acids, contain in cells of all live organisms and in viruses).
"The
idea is in delivering anti-virus RNA, having closed it in a microcontainer, in
those cells, which allocate few interferon (the proteins produced in response
to a virus) at organism infection with a virus. Introduction to a cell of
genetic material is resulted by blocking of a virus genome that leads to
decrease in a reproduction of a virus of influenza", – the employee of
laboratory Alexander Timin is quoted in the message.
It is
explained that the patient will need to inhale a microcontainer, it will break
up in nasal sinuses and release RNA, which will get to cells subsequently that
finally will lead to rising of immunity against the influenza virus.
"The
first laboratory experiments showed that content of virus protein decreases
more than by 80%. It allows to speak about the serious potential of technology.
One of the main problems of medicine is that viruses learned to evolve quickly
that complicates process of development of effective antiviral medicines",
– Timin added.